82 related articles for article (PubMed ID: 23066773)
1. Quetiapine-induced insulin resistance after switching from blonanserin despite a loss in both bodyweight and waist circumference.
Suzuki Y; Sugai T; Fukui N; Watanabe J; Ono S; Tsuneyama N; Saito M; Someya T
Psychiatry Clin Neurosci; 2012 Oct; 66(6):534-5. PubMed ID: 23066773
[No Abstract] [Full Text] [Related]
2. Improvement in quetiapine-induced hypoglycemia following a switch to blonanserin.
Suzuki Y; Tsuneyama N; Sugai T; Fukui N; Watanabe J; Ono S; Saito M; Someya T
Psychiatry Clin Neurosci; 2012 Jun; 66(4):370-1. PubMed ID: 22624745
[No Abstract] [Full Text] [Related]
3. Efficacy and tolerability of Blonanserin in the patients with schizophrenia: a randomized, double-blind, risperidone-compared trial.
Yang J; Bahk WM; Cho HS; Jeon YW; Jon DI; Jung HY; Kim CH; Kim HC; Kim YK; Kim YH; Kwon JS; Lee SY; Lee SH; Yi JS; Yoon BH; Kim SH
Clin Neuropharmacol; 2010 Jul; 33(4):169-75. PubMed ID: 20661022
[TBL] [Abstract][Full Text] [Related]
4. Weight loss and anorexia with quetiapine.
Khawaja IS; Azeem MW; Ebrahim A
Psychiatr Serv; 2005 Apr; 56(4):490. PubMed ID: 15812105
[No Abstract] [Full Text] [Related]
5. [Blonanserin in the treatment of schizophrenia].
Tenjin T; Miyamoto S
Nihon Rinsho; 2013 Apr; 71(4):660-5. PubMed ID: 23678596
[TBL] [Abstract][Full Text] [Related]
6. One-year follow-up study of psychotic patients treated with blonanserin: a case series.
Takahashi S; Suzuki M; Uchiyama M
Asia Pac Psychiatry; 2013 Sep; 5(3):164-7. PubMed ID: 23857800
[TBL] [Abstract][Full Text] [Related]
7. Blonanserin, a novel antipsychotic, is suitable for treating schizophrenia associated with hyperprolactinemia: a case series.
Kawabe K; Horiuchi F; Ueno S
Clin Neuropharmacol; 2013; 36(6):239-41. PubMed ID: 24201238
[TBL] [Abstract][Full Text] [Related]
8. Adjunctive treatment with low-dosage aripiprazole for blonanserin-induced hyperprolactinemia in a female patient with schizophrenia.
Ishitobi M; Kosaka H; Shukunami K; Murata T; Wada Y
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1361-2. PubMed ID: 20647025
[No Abstract] [Full Text] [Related]
9. A prospective study of glucose homeostasis in quetiapine-treated schizophrenic patients by using the intravenous glucose tolerance test.
Chen CH; Lin TY; Chen TT; Chen VC; Lin NC; Shao WC; Lu ML
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):965-9. PubMed ID: 21291941
[TBL] [Abstract][Full Text] [Related]
10. Three cases of schizophrenia showing improvement after switching to blonanserin.
Kurotaki N; Nobata H; Nonaka S; Nishihara K; Ozawa H
Psychiatry Clin Neurosci; 2011 Jun; 65(4):396-7. PubMed ID: 21682816
[No Abstract] [Full Text] [Related]
11. Treatment-emergent tardive dyskinesia with quetiapine in mood disorders.
Sharma V
J Clin Psychopharmacol; 2003 Aug; 23(4):415-7. PubMed ID: 12920421
[No Abstract] [Full Text] [Related]
12. Quetiapine and elevated creatine phosphokinase (CK).
Plesnicar BK; Lasic JK; Plesnicar A
Pharmacopsychiatry; 2007 Sep; 40(5):203-4. PubMed ID: 17874354
[No Abstract] [Full Text] [Related]
13. Blonanserin: a review of its use in the management of schizophrenia.
Deeks ED; Keating GM
CNS Drugs; 2010 Jan; 24(1):65-84. PubMed ID: 20030420
[TBL] [Abstract][Full Text] [Related]
14. Sexual disinhibition in schizophrenia possibly induced by risperidone and quetiapine.
Lam MH; Fong SY; Wing YK
Psychiatry Clin Neurosci; 2007 Jun; 61(3):333. PubMed ID: 17472606
[No Abstract] [Full Text] [Related]
15. The relationship between the plasma concentration of blonanserin, and its plasma anti-serotonin 5-HT(2A) activity/anti-dopamine D₂ activity ratio and drug-induced extrapyramidal symptoms.
Suzuki H; Gen K
Psychiatry Clin Neurosci; 2012 Mar; 66(2):146-52. PubMed ID: 22353327
[TBL] [Abstract][Full Text] [Related]
16. Increased libido associated with quetiapine.
Menon A; Williams RH; Watson S
J Psychopharmacol; 2006 Jan; 20(1):125-7. PubMed ID: 16354735
[TBL] [Abstract][Full Text] [Related]
17. Quetiapine-induced leucopenia.
Alexander J; Tibrewal P
Aust N Z J Psychiatry; 2010 Aug; 44(8):767-8. PubMed ID: 20636202
[No Abstract] [Full Text] [Related]
18. Quetiapine-associated acute dystonia.
Kropp S; Hauser U; Ziegenbein M
Ann Pharmacother; 2004 Apr; 38(4):719-20. PubMed ID: 14966260
[No Abstract] [Full Text] [Related]
19. Weight gain--as possible predictor of metabolic syndrome.
Grahovac T; Ružić K; Dadić-Hero E; Sepić-Grahovac D; Sabljić V
Psychiatr Danub; 2011 Mar; 23(1):105-7. PubMed ID: 21448110
[TBL] [Abstract][Full Text] [Related]
20. Repeated acute dystonia following administration of amisulpride and ziprasidone in a patient with iron deficiency.
Chen HK; Chen CK; Tzeng NS
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1615-6. PubMed ID: 18597910
[No Abstract] [Full Text] [Related]
[Next] [New Search]
